CNS Drug Reviews

Titel Veröffentlichungsdatum Sprache Zitate
Paracetamol: New Vistas of an Old Drug2006/09/01English384
A Review of the Pharmacological and Clinical Profile of Mirtazapine2001/09/01English348
Pharmacological Profile of the Selective FAAH Inhibitor KDS-4103 (URB597)2006/03/01English327
Neuroprotective Effects of Edaravone: a Novel Free Radical Scavenger in Cerebrovascular Injury2006/03/01English288
Lacosamide: A Review of Preclinical Properties2007/03/01English271
The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease2003/09/01English243
Valproate: Past, Present, and Future2003/06/01English228
Galantamine — a Novel Cholinergic Drug with a Unique Dual Mode of Action for the Treatment of Patients with Alzheimer's Disease2002/06/01English185
BMS‐204352: A Potassium Channel Opener Developed for the Treatment of Stroke2002/12/01English177
Piracetam: A Review of Pharmacological Properties and Clinical Uses2005/03/01English167
Review of the Pharmacology and Clinical Profile of Bupropion, an Antidepressant and Tobacco Use Cessation Agent2006/09/01English167
Paroxetine: A Review2001/03/01English159
SCH 23390: The First Selective Dopamine D1‐Like Receptor Antagonist2001/12/01English157
Phenibut (β‐Phenyl‐GABA): A Tranquilizer and Nootropic Drug2001/12/01English156
The Selective Norepinephrine Reuptake Inhibitor Antidepressant Reboxetine: Pharmacological and Clinical Profile2004/03/01English155
Moclobemide: Therapeutic Use and Clinical Studies2003/03/01English139
The Antidepressant and Antiinflammatory Effects of Rolipram in the Central Nervous System2001/12/01English137
Catechol‐O‐methyltransferase and Its Inhibitors in Parkinson's Disease2007/09/01English137
A New Look at the 5?-Reductase Inhibitor Finasteride2006/03/01English127
Metabotropic Glutamate Receptor Subtype 5 Antagonists MPEP and MTEP2006/06/01English119
The Pharmacology of Physostigmine1998/06/01English115
Aripiprazole: A Novel Atypical Antipsychotic Drug With a Uniquely Robust Pharmacology2004/12/01English109
Pharmacology of Flibanserin2002/06/01English100
Therapeutic Potential of Wogonin: A Naturally Occurring Flavonoid2005/03/01English99
Involvement of Calpain Activation in Neurodegenerative Processes2006/06/01English96
Ondansetron: A Selective 5‐HT3 Receptor Antagonist and Its Applications in CNS‐Related Disorders2001/06/01English95
A New Look at the Respiratory Stimulant Doxapram2006/09/01English93
Xanomeline and the Antipsychotic Potential of Muscarinic Receptor Subtype Selective Agonists2003/06/01English89
NAP: Research and Development of a Peptide Derived from Activity-Dependent Neuroprotective Protein (ADNP)2006/06/07English88
Retigabine: Chemical Synthesis to Clinical Application2006/06/07English88